Rodrigo Catalán Cárdenas (Rodrigo Catalán)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Systematic Review

Tyrosine Kinase

Neuroendocrine Tumors

Long Noncoding Rna

Top Venues

Journal of immunology research

Clinical and translational science

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alberto Guijosa, Ana Freyria, Jose Rodrigo Espinosa-Fernandez, Francisco J Estrada-Mena, Ana Sofía Armenta-Quiroga, Maria Fernanda Ortega-Treviño, Rodrigo Catalán Cárdenas, Bani Antonio-Aguirre, Cynthia Villarreal Garza, Andric C Perez-Ortiz
Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis. Clinical and translational science 15 (10) (2022)
Mario Orozco-Morales, Alejandro Avilés-Salas, Norma Hernández-Pedro, Rodrigo Catalán Cárdenas, Graciela Cruz-Rico, Ana Laura Colín-González, Elsa Dosal-Mancilla, Pedro Barrios-Bernal, Arrieta Oscar
Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors. Journal of immunology research 2021 (2021)
Abril Marcela Herrera-Solorio, Irlanda Peralta-Arrieta, Leonel Armas López, Nallely Hernández-Cigala, Criselda Mendoza Milla, Blanca Ortiz Quintero, Rodrigo Catalán Cárdenas, Priscila Pineda Villegas, Evelyn Rodríguez Villanueva, Cynthia G Trejo Iriarte, Joaquín Zúñiga, Arrieta Oscar, Federico Ávila-Moreno
LncRNA SOX2-OT regulates AKT/ERK and SOX2/GLI-1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases. Molecular oncology 15 (4) (2020)